TLR2 Stimulation Increases Cellular Metabolism in CD8+ T Cells and Thereby Enhances CD8+ T Cell Activation, Function, and Antiviral Activity
暂无分享,去创建一个
Jia Liu | Zhiyong Ma | Mengji Lu | E. Zhang | Hu Yan | Qian Li | Weimin Wu | C. Kirschning | Haifeng C Xu | U. Dittmer | Dongliang Yang | Philipp A Lang | Xiaoyong Zhang | Jiabao Guo | Philipp A. Lang | Haifeng C. Xu
[1] B. Nicolet,et al. Costimulation through TLR2 Drives Polyfunctional CD8+ T Cell Responses , 2018, The Journal of Immunology.
[2] Jia Liu,et al. Pre-Activation of Toll-Like Receptor 2 Enhances CD8+ T-Cell Responses and Accelerates Hepatitis B Virus Clearance in the Mouse Models , 2018, Front. Immunol..
[3] Mengji Lu,et al. Differentially Expressed Intrahepatic Genes Contribute to Control of Hepatitis B Virus Replication in the Inactive Carrier Phase , 2018, The Journal of infectious diseases.
[4] D. Pei,et al. Toll-like receptor 2 costimulation potentiates the antitumor efficacy of CAR T Cells , 2018, Leukemia.
[5] Jia Liu,et al. TLR2 Stimulation Strengthens Intrahepatic Myeloid-Derived Cell-Mediated T Cell Tolerance through Inducing Kupffer Cell Expansion and IL-10 Production , 2018, The Journal of Immunology.
[6] Zhiyong Ma,et al. Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B , 2018, Vaccines.
[7] Jia Liu,et al. TLR2 Expression in Peripheral CD4+ T Cells Promotes Th17 Response and Is Associated with Disease Aggravation of Hepatitis B Virus-Related Acute-On-Chronic Liver Failure , 2017, Front. Immunol..
[8] J. Buer,et al. The IL-1R/TLR signaling pathway is essential for efficient CD8+ T-cell responses against hepatitis B virus in the hydrodynamic injection mouse model , 2017, Cellular & Molecular Immunology.
[9] M. Ferracin,et al. Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B , 2017, Nature Medicine.
[10] D. Veale,et al. Resolution of TLR2-induced inflammation through manipulation of metabolic pathways in Rheumatoid Arthritis , 2017, Scientific Reports.
[11] V. Boussiotis. Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway. , 2016, The New England journal of medicine.
[12] E. Wherry,et al. Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion. , 2016, Immunity.
[13] C. Frezza,et al. Distinct Metabolic Requirements of Exhausted and Functional Virus-Specific CD8 T Cells in the Same Host , 2016, Cell reports.
[14] M. Wolkers,et al. TLR-Mediated Innate Production of IFN-γ by CD8+ T Cells Is Independent of Glycolysis , 2016, The Journal of Immunology.
[15] T. Block,et al. Chronic hepatitis B: A wave of new therapies on the horizon. , 2015, Antiviral research.
[16] A. Kallies,et al. Synchronizing transcriptional control of T cell metabolism and function , 2015, Nature Reviews Immunology.
[17] B. Liao,et al. Aberrant expression and dysfunction of TLR2 and its soluble form in chronic HBV infection and its regulation by antiviral therapy. , 2015, Antiviral research.
[18] Zhiyong Ma,et al. Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses , 2014, Cellular and Molecular Immunology.
[19] A. Bertoletti,et al. The immune tolerant phase of chronic HBV infection: new perspectives on an old concept , 2014, Cellular and Molecular Immunology.
[20] Linda V. Sinclair,et al. Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells , 2015, Nature Medicine.
[21] Baoju Wang,et al. Woodchuck hepatitis virus core antigen-based DNA and protein vaccines induce qualitatively different immune responses that affect T cell recall responses and antiviral effects. , 2015, Virology.
[22] Mengji Lu,et al. Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection , 2014, Medical Microbiology and Immunology.
[23] R. Thimme,et al. Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation. , 2014, Journal of hepatology.
[24] A. Regev,et al. The transcription factor BATF operates as an essential differentiation checkpoint in early effector CD8+ T cells , 2014, Nature Immunology.
[25] D. Scott‐Algara,et al. Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial—ANRS HB02 VAC-ADN , 2014, Gut.
[26] Jia Liu,et al. Enhancing Virus-Specific Immunity In Vivo by Combining Therapeutic Vaccination and PD-L1 Blockade in Chronic Hepadnaviral Infection , 2014, PLoS pathogens.
[27] O. Dirsch,et al. Novel Woodchuck Hepatitis Virus (WHV) Transgene Mouse Models Show Sex-Dependent WHV Replicative Activity and Development of Spontaneous Immune Responses to WHV Proteins , 2013, Journal of Virology.
[28] M. Kaplan,et al. Interferon regulatory factor 4 sustains CD8(+) T cell expansion and effector differentiation. , 2013, Immunity.
[29] Jia Liu,et al. TLR1/2 Ligand–Stimulated Mouse Liver Endothelial Cells Secrete IL-12 and Trigger CD8+ T Cell Immunity In Vitro , 2013, The Journal of Immunology.
[30] W. Shi,et al. The transcription factor IRF4 is essential for TCR affinity–mediated metabolic programming and clonal expansion of T cells , 2013, Nature Immunology.
[31] Y. Wen,et al. Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: experiences and findings. , 2013, Journal of hepatology.
[32] Jia Liu,et al. Combination of DNA Prime – Adenovirus Boost Immunization with Entecavir Elicits Sustained Control of Chronic Hepatitis B in the Woodchuck Model , 2013, PLoS pathogens.
[33] Zhenghong Yuan,et al. Hepatitis B Virus Surface Antigen Selectively Inhibits TLR2 Ligand–Induced IL-12 Production in Monocytes/Macrophages by Interfering with JNK Activation , 2013, The Journal of Immunology.
[34] J. Rathmell,et al. Metabolic regulation of T lymphocytes. , 2013, Annual review of immunology.
[35] W. Rosenberg,et al. The Third Signal Cytokine IL-12 Rescues the Anti-Viral Function of Exhausted HBV-Specific CD8 T Cells , 2013, PLoS pathogens.
[36] D. Green,et al. Metabolic checkpoints in activated T cells , 2012, Nature Immunology.
[37] Jia Liu,et al. Role of Toll-like receptor 2 in the immune response against hepadnaviral infection. , 2012, Journal of hepatology.
[38] Mengji Lu,et al. DNA Prime-Adenovirus Boost Immunization Induces a Vigorous and Multifunctional T-Cell Response against Hepadnaviral Proteins in the Mouse and Woodchuck Model , 2012, Journal of Virology.
[39] A. Bertoletti,et al. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection , 2011, Gut.
[40] T. Sparwasser,et al. Transient depletion of regulatory T cells in transgenic mice reactivates virus-specific CD8+ T cells and reduces chronic retroviral set points , 2011, Proceedings of the National Academy of Sciences.
[41] S. Markovic,et al. Cancer esearch oenvironment and Immunology plifying TLR-MyD 88 Signals within Tumor-Specific ells Enhances Antitumor Activity to Suboptimal R els of Weakly Immunogenic Tumor , 2010 .
[42] E. Davila,et al. When Toll-like receptor and T-cell receptor signals collide: a mechanism for enhanced CD8 T-cell effector function. , 2010, Blood.
[43] G. Gerken,et al. Toll‐like receptor‐induced innate immune responses in non‐parenchymal liver cells are cell type‐specific , 2010, Immunology.
[44] F. Chisari,et al. Immune effectors required for hepatitis B virus clearance , 2009, Proceedings of the National Academy of Sciences.
[45] L. Turka,et al. The contribution of direct TLR signaling to T cell responses , 2009, Immunologic research.
[46] J. Marvel,et al. TLR2 Engagement on CD8 T Cells Enables Generation of Functional Memory Cells in Response to a Suboptimal TCR Signal1 , 2009, The Journal of Immunology.
[47] Zhan-qing Zhang,et al. Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients. , 2008, Clinical immunology.
[48] Lieping Chen,et al. Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy. , 2007, Blood.
[49] G. Gerken,et al. Interferon-alpha response in chronic hepatitis B-transfected HepG2.2.15 cells is partially restored by lamivudine treatment. , 2007, World journal of gastroenterology.
[50] S. Riordan,et al. Reduced Expression of Toll-Like Receptor 2 on Peripheral Monocytes in Patients with Chronic Hepatitis B , 2006, Clinical and Vaccine Immunology.
[51] S. Akira,et al. TLR2 engagement on CD8 T cells lowers the thresholdfor optimal antigen‐induced T cell activation , 2006, European journal of immunology.
[52] L. Jones,et al. TLR2 is expressed on activated T cells as a costimulatory receptor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[53] W. Lindenmaier,et al. Enhanced Effector and Memory CTL Responses Generated by Incorporation of Receptor Activator of NF-κB (RANK)/RANK Ligand Costimulatory Molecules into Dendritic Cell Immunogens Expressing a Human Tumor-Specific Antigen 12 , 2003, The Journal of Immunology.
[54] R. Purcell,et al. CD8+ T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection , 2003, Journal of Virology.
[55] D. Green,et al. Nonlymphoid Fas ligand in peptide-induced peripheral lymphocyte deletion , 2002, Proceedings of the National Academy of Sciences of the United States of America.